Skip to main content

Shoulder Impingement

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Relief Therapeutics
Relief TherapeuticsSwitzerland - Geneva
1 program
Outcome Measures for Pediatric Wheelchairs in Low-resource SettingsN/A1 trial
Active Trials
NCT01530425Terminated100Est. Dec 2014
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Strengthening groupN/A1 trial
Active Trials
NCT02164305Completed42Est. Oct 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Oregon TherapeuticsStrengthening group
Relief TherapeuticsOutcome Measures for Pediatric Wheelchairs in Low-resource Settings

Clinical Trials (2)

Total enrollment: 142 patients across 2 trials

The Effects of Exercise Training on Shoulder Neuromuscular Control

Start: May 2014Est. completion: Oct 201542 patients
N/ACompleted
NCT01530425Relief TherapeuticsOutcome Measures for Pediatric Wheelchairs in Low-resource Settings

Outcome Measures for Pediatric Wheelchairs in Low-resource Settings

Start: Mar 2011Est. completion: Dec 2014100 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.